BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 23667969)

  • 1. [Severe delayed drug hypersensitivity reactions].
    Maniu CM; Buss G; Feldmeyer L; Spertini F; Ribi C
    Rev Med Suisse; 2013 Apr; 9(382):803-4, 806-11. PubMed ID: 23667969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Hypersensitivity Reactions.
    Wilkerson RG
    Immunol Allergy Clin North Am; 2023 Aug; 43(3):473-489. PubMed ID: 37394254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Harr T; French LE
    Med Clin North Am; 2010 Jul; 94(4):727-42, x. PubMed ID: 20609860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS).
    Belver MT; Michavila A; Bobolea I; Feito M; Bellón T; Quirce S
    Allergol Immunopathol (Madr); 2016; 44(1):83-95. PubMed ID: 26089185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approach to the patient with a suspected drug eruption.
    Cotliar J
    Semin Cutan Med Surg; 2007 Sep; 26(3):147-54. PubMed ID: 18070681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenytoin-associated hypersensitivity syndrome with features of DRESS and TEN/SJS.
    Viera MH; Perez OA; Patel JK; Jones I; Berman B
    Cutis; 2010 Jun; 85(6):312-7. PubMed ID: 20666193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification.
    Wolf R; Matz H; Marcos B; Orion E
    Clin Dermatol; 2005; 23(3):311-4. PubMed ID: 15896547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Drug Hypersensitivity Reactions: Clinical Pattern, Diagnosis, Etiology and Therapeutic Options.
    Paulmann M; Mockenhaupt M
    Curr Pharm Des; 2016; 22(45):6852-6861. PubMed ID: 27779083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-threatening acute adverse cutaneous drug reactions.
    Wolf R; Orion E; Marcos B; Matz H
    Clin Dermatol; 2005; 23(2):171-81. PubMed ID: 15802211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
    Sane SP; Bhatt AD
    J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson syndrome and toxic epidermal necrolysis: what do we know?
    Tartarone A; Lerose R
    Ther Drug Monit; 2010 Dec; 32(6):669-72. PubMed ID: 20844465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS].
    Bensaïd B; Valeyrie-Allanore L; Lebrun-Vignes B; Nicolas JF
    Rev Prat; 2015 Sep; 65(7):981-5. PubMed ID: 26619740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis.
    Romano A; Caubet JC
    J Allergy Clin Immunol Pract; 2014; 2(1):3-12. PubMed ID: 24565763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Oliveira A; Sanches M; Selores M
    Acta Med Port; 2011 Dec; 24 Suppl 4():995-1002. PubMed ID: 22863510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug allergy].
    Sueki H
    Nihon Rinsho; 2009 Nov; 67(11):2139-43. PubMed ID: 19899530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking.
    Walsh SA; Creamer D
    Clin Exp Dermatol; 2011 Jan; 36(1):6-11. PubMed ID: 21143513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The major SCAR syndromes].
    Piérard GE; Lesuisse M; Piérard-Franchimont C
    Rev Med Liege; 2017 Oct; 72(10):444-447. PubMed ID: 29058836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approach to the acute, generalized, blistering patient.
    Carr DR; Houshmand E; Heffernan MP
    Semin Cutan Med Surg; 2007 Sep; 26(3):139-46. PubMed ID: 18070680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions.
    Barbaud A; Collet E; Milpied B; Assier H; Staumont D; Avenel-Audran M; Grange A; Amarger S; Girardin P; Guinnepain MT; Truchetet F; Lasek A; Waton J;
    Br J Dermatol; 2013 Mar; 168(3):555-62. PubMed ID: 23136927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Treat J
    Pediatr Ann; 2010 Oct; 39(10):667-9, 672-4. PubMed ID: 20954613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.